Oncolytics Biotech (ONCY) FCF Margin (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly FCF Margin came in at 6523.08% in Q3 2025, up 2425948.0% year-on-year from N/an in Q3 2024, and up 136.78% on a QoQ basis from 17736.39% in Q3 2024.
Oncolytics Biotech (ONCY) FCF Margin (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 10 years of FCF Margin data on file, last reported at 6523.08% in Q3 2025.
- On a quarterly basis, FCF Margin rose 2425948.0% year-over-year to 6523.08% in Q3 2025; TTM through Sep 2025 was 28.76%, a 1044.0% decrease from a year earlier, with the FY2018 full-year figure at 87.61%, changed N/A from the prior year.
- FCF Margin for Q3 2025 stood at 6523.08%, up from 17736.39% in the prior quarter.
- Over the last five years, FCF Margin for ONCY reached as high as 6523.08% in Q3 2025 and fell as low as 17736.39% in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6,523.08% |
| Sep 30, 2024 | -17,736.39% |
| Sep 30, 2020 | -14.67% |
| Jun 30, 2020 | -13.04% |
| Mar 31, 2020 | -8.52% |
| Sep 30, 2019 | -36.73% |
| Jun 30, 2019 | -38.63% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 32.07% |
| Sep 30, 2018 | 21,874.36% |
| Jun 30, 2017 | 0.00% |
| Jun 30, 2016 | 368.40% |
| Jun 30, 2011 | 351.03% |
| Sep 30, 2010 | -1,599.14% |
| Jun 30, 2010 | -665.64% |
| Mar 31, 2009 | -43.04% |